Alpha Teknova Inc (TKNO) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Alpha Teknova Inc (TKNO) has a cash flow conversion efficiency ratio of -0.052x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-3.36 Million) by net assets ($64.92 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Alpha Teknova Inc (TKNO) liquidity interval to measure how many days the company can operate on defensive assets alone.
Alpha Teknova Inc - Cash Flow Conversion Efficiency Trend (2019–2025)
This chart illustrates how Alpha Teknova Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Alpha Teknova Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Alpha Teknova Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
The Lovesac Company
NASDAQ:LOVE
|
-0.172x |
|
Metropolitan Land Tbk
JK:MTLA
|
0.006x |
|
Walchandnagar Industries Limited
NSE:WALCHANNAG
|
0.035x |
|
Grupo Minsa S.A.B. de C.V
MX:MINSAB
|
0.009x |
|
EMS Limited
NSE:EMSLIMITED
|
-0.029x |
|
CCS Supply Chain Management Co Ltd
SHG:600180
|
0.052x |
|
Lotte Data Communication Company
KO:286940
|
-0.004x |
|
Xplora Technologies As
OL:XPLRA
|
0.295x |
Annual Cash Flow Conversion Efficiency for Alpha Teknova Inc (2019–2025)
The table below shows the annual cash flow conversion efficiency of Alpha Teknova Inc from 2019 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Alpha Teknova Inc worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $68.78 Million | $-8.65 Million | -0.126x | +16.41% |
| 2024-12-31 | $82.39 Million | $-12.39 Million | -0.150x | +28.03% |
| 2023-12-31 | $90.04 Million | $-18.81 Million | -0.209x | +23.82% |
| 2022-12-31 | $99.89 Million | $-27.40 Million | -0.274x | -333.15% |
| 2021-12-31 | $143.20 Million | $-9.07 Million | -0.063x | -232.49% |
| 2020-12-31 | $52.41 Million | $2.50 Million | 0.048x | -71.59% |
| 2019-12-31 | $12.91 Million | $2.17 Million | 0.168x | -- |
About Alpha Teknova Inc
Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company' primary products include pre-poured media plates for cell growth and cloning; liquid microbial culture media and supplements for cellular expansion; and molecular biology reagents for sam… Read more